According to Madrigal Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -S$0.65 B. In 2023 the company made an earning of -S$0.48 B a decrease over its 2022 earnings that were of -S$0.38 B.The earnings displayed on this page is the company's Pretax Income.